PT  - JOURNAL ARTICLE
AU  - Lau, Vincent I.
AU  - Mah, Graham D.
AU  - Wang, Xiaoming
AU  - Byker, Leon
AU  - Robinson, Andrea
AU  - Milovanovic, Lazar
AU  - Alherbish, Aws
AU  - Odenbach, Jeffrey
AU  - Vadeanu, Cristian
AU  - Lu, David
AU  - Smyth, Leo
AU  - Rohatensky, Mitchell
AU  - Whiteside, Brian
AU  - Gregoirev, Phillip
AU  - Luksun, Warren
AU  - van Diepen, Sean
AU  - Anderson, Dustin
AU  - Verma, Sanam
AU  - Slemkov, Jocelyn
AU  - Brindley, Peter
AU  - Kustogiannis, Demetrios J.
AU  - Jacka, Michael
AU  - Shaw, Andrew
AU  - Wheatley, Matt
AU  - Windram, Jonathan
AU  - Opgenorth, Dawn
AU  - Baig, Nadia
AU  - Rewa, Oleksa G.
AU  - Bagshaw, Sean M.
AU  - Buchanan, Brian M.
TI  - Intra-pulmonary and intra-cardiac shunts in adult COVID-19 versus non-COVID ARDS ICU patients using echocardiography and contrast bubble studies (COVID-Shunt Study): a prospective, observational cohort study
AID  - 10.1101/2022.08.04.22278445
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.08.04.22278445
4099  - http://medrxiv.org/content/early/2022/08/06/2022.08.04.22278445.short
4100  - http://medrxiv.org/content/early/2022/08/06/2022.08.04.22278445.full
AB  - Importance Studies have suggested intra-pulmonary shunts may contribute to hypoxemia in COVID-19 ARDS and may be associated with worse outcomes.Objective To evaluate the presence of right-to-left (R-L) shunts in COVID-19 and non-COVID ARDS patients using a comprehensive hypoxemia work-up for shunt etiology and associations with mortality.Design, Setting, Participants We conducted a multi-centre (4 Canadian hospitals), prospective, observational cohort study of adult critically ill, mechanically ventilated, ICU patients admitted for ARDS from both COVID-19 or non-COVID (November 16, 2020-September 1, 2021).Intervention Contrast-enhanced agitated-saline bubble studies with transthoracic echocardiography/transcranial Doppler (TTE/TCD) ± transesophageal echocardiography (TEE) assessed for the presence of R-L shunts.Main Outcomes and Measures Primary outcomes were shunt incidence and association with hospital mortality. Logistic regression analysis was used to determine association of shunt presence/absence with covariables.Results The study enrolled 226 patients (182 COVID-19 vs. 42 non-COVID). Median age was 58 years (interquartile range [IQR]: 47-67) and APACHE II scores of 30 (IQR: 21-36). In COVID-19 patients, the incidence of R-L shunt was 31/182 patients (17.0%; intra-pulmonary: 61.3%; intra-cardiac: 38.7%) versus 10/44 (22.7%) non-COVID patients. No evidence of difference was detected between the COVID-19 and non-COVID-19 shunt rates (risk difference [RD]: -5.7%, 95% CI: -18.4-7.0, p=0.38). In the COVID-19 group, hospital mortality was higher for those with R-L shunt compared to those without (54.8% vs 35.8%, RD: 19.0%, 95% CI 0.1-37.9, p=0.05). But this did not persist at 90-day mortality, nor after regression adjustments for age and illness severity.Conclusions There was no evidence of increased R-L shunt rates in COVID-19 compared to non-COVID controls. Right-to-left shunt was associated with increased in-hospital mortality for COVID-19 patients, but this did not persist at 90-day mortality or after adjusting using logistic regression.Question Does right-to-left shunt incidence increase with COVID-19 ARDS compared to non-COVID, and is there association with shunt incidence and mortality?Findings In this prospective, observational cohort study, we showed no statistically significant difference in shunt prevalence between COVID-19 ARDS patients (17.0%) and non-COVID patients (22.7%). However, in COVID-19 patients, there was a difference in hospital mortality for those with shunt (54.8%) compared to those without shunt (35.8%), but this difference did not persist at 90-day mortality, nor after regression adjustments for age and illness severity.Meaning There was no evidence of increased R-L shunt rates in COVID-19 compared to non-COVID or historical controls. Right-to-left shunt presence was associated with increased hospital mortality for COVID-19 patients, but this did not persist for 90-day mortality or after adjustment using logistic regression.Competing Interest StatementDr. Bagshaw is supported by a Canada Research Chair in Critical Care Outcomes and Systems Evaluation. None of the other authors disclose any competing interests.Funding StatementThis work was supported by grants from the University of Alberta Hospital Foundation, Royal Alexandra Hospital Foundation, and the Covenant Foundation at the Grey Nuns Hospital for Drs. Lau, Buchanan, Robinson, Byker.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and fully approved by the local institutional review board (University of Alberta Research Ethics Board: PRO00104364).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors